Abreva and Application site scab - a phase IV clinical study of FDA data

Summary:

Application site scab is found among people who take Abreva, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Abreva and have Application site scab. It is created by eHealthMe based on reports of 16,308 people who have side effects when taking Abreva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 30, 2022

16,308 people reported to have side effects when taking Abreva.
Among them, 172 people (1.05%) have Application site scab.


What is Abreva?

Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,320 Abreva users for its effectiveness, alternative drugs and more.

What is Application site scab?

Application site scab (hard coating on the skin formed at application site) is found to be associated with 369 drugs and 256 conditions by eHealthMe.

Number of Abreva and Application site scab reports submitted per year:

Could Abreva cause Application site scab?

Time on Abreva when people have Application site scab *:

Click here to view

Gender of people who have Application site scab when taking Abreva*:

Click here to view

Age of people who have Application site scab when taking Abreva *:

Click here to view

Common drugs people take besides Abreva *:

Click here to view

Common side effects people have besides Application site scab *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Abreva and have Application site scab?

Check whether Application site scab is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Application site scab and when was it recovered:

Expand to all the drugs that have ingredients of docosanol:

Alternative drugs to, pros and cons of Abreva:

Common Abreva side effects:

Browse all side effects of Abreva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Application site scab treatments and more:

COVID vaccines that are related to Application site scab:

Common drugs associated with Application site scab:

All the drugs that are associated with Application site scab:

Common conditions associated with Application site scab:

All the conditions that are associated with Application site scab:

How the study uses the data?

The study uses data from the FDA. It is based on docosanol (the active ingredients of Abreva) and Abreva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: